My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lemsip Decongestant & Flu Capsules with CaffeineParacetamol 500mgPhenylephine Hydrochloride 6.1mgCaffeine 25mg



Reckitt Benckiser Ireland LtdPA0979/027/001

Main Information

Trade NameLemsip Decongestant & Flu Capsules with CaffeineParacetamol 500mgPhenylephine Hydrochloride 6.1mgCaffeine 25mg
Active SubstancesParacetamol
Phenylephrine hydrochloride
Caffeine anhydrous
Dosage FormCapsule, hard
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/027/001

Group Information

ATC CodeN02BE Anilides
N02BE51 paracetamol, combinations excl. psycholeptics

Status

License statusAuthorised
Licence Issued30/11/2007
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicencePharmacy only: MAXIMUM PACK SIZE 24. Maximum two packs per sale. Prescription only: Pack size greater than 24. Product not supplied in blister packs. Promotion to the public: Pack size not more than 24 Promotion to Healthcare professionals: Pack size greater than 24
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print